Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.10
-0.0400-3.51%
Volume:35.91K
Turnover:39.64K
Market Cap:16.65M
PE:-1.49
High:1.13
Open:1.13
Low:1.08
Close:1.14
52wk High:2.29
52wk Low:0.7500
Shares:15.14M
Float Shares:12.12M
Volume Ratio:0.24
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:6.17
PE(LYR):-0.89

Loading ...

BioCardia Q1 EPS $(0.21) Misses $(0.17) Estimate

Benzinga Earnings
·
May 15

BioCardia, Inc. Q1 Net Income USD -2.259 Million

Reuters
·
May 15

BioCardia Q1 net loss narrows as expenses decline

Reuters
·
May 15

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Operating Income USD -2.266 Million

THOMSON REUTERS
·
May 15

BioCardia, Inc. Q1 Basic EPS USD -0.21

THOMSON REUTERS
·
May 15

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 14

BioCardia schedules first-quarter earnings conference call, corporate update

Reuters
·
May 12

BioCardia provides update on Helix pre-submission meeting with FDA

TIPRANKS
·
May 09

BioCardia Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 08

BioCardia Inc - FDA Prefers Helix Approval Simultaneous With Cardiamp Cell Therapy System Approval

THOMSON REUTERS
·
May 08

BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Agrees on Two Pathways for Helix Marketing Clearance, No Safety Concerns Raised

THOMSON REUTERS
·
May 08

BioCardia Inc - FDA Suggests Follow-on Pre-Submission Could Enable Helix Approval via Denovo Pathway

THOMSON REUTERS
·
May 08

BioCardia CEO Peter Altman acquires 5,000 common shares for $5,550

Reuters
·
Apr 30

BioCardia Gains Japanese Patent for Heart3D Imaging Technology

TIPRANKS
·
Apr 28

BioCardia says Japan allows patent for Heart3D fusion imaging software

Reuters
·
Apr 28

BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3d™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During Cardiamp Cell Therapy Procedures

THOMSON REUTERS
·
Apr 28

BioCardia CEO Peter Altman buys $1,230 common shares

Reuters
·
Apr 23

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

TIPRANKS
·
Apr 20